These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

838 related articles for article (PubMed ID: 33475151)

  • 21. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Tudur Smith C; Weston J; Marson AG
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD001031. PubMed ID: 27841445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-seizure medications for Lennox-Gastaut syndrome.
    Brigo F; Jones K; Eltze C; Matricardi S
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD003277. PubMed ID: 33825230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonazepam monotherapy for treating people with newly diagnosed epilepsy.
    Brigo F; Igwe SC; Bragazzi NL; Lattanzi S
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Tudur Smith C
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001904. PubMed ID: 30353945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brivaracetam add-on therapy for drug-resistant epilepsy.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD011501. PubMed ID: 35285519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gabapentin add-on treatment for drug-resistant focal epilepsy.
    Panebianco M; Al-Bachari S; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD001415. PubMed ID: 33434292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stiripentol add-on therapy for drug-resistant focal epilepsy.
    Brigo F; Igwe SC; Bragazzi NL
    Cochrane Database Syst Rev; 2020 May; 5(5):CD009887. PubMed ID: 32468572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure.
    Leone MA; Giussani G; Nevitt SJ; Marson AG; Beghi E
    Cochrane Database Syst Rev; 2021 May; 5(5):CD007144. PubMed ID: 33942281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001911. PubMed ID: 28240353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lamotrigine add-on for drug-resistant partial epilepsy.
    Ramaratnam S; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001909. PubMed ID: 27329345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003615. PubMed ID: 30350354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD001904. PubMed ID: 27976799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatments for seizures in catamenial (menstrual-related) epilepsy.
    Maguire MJ; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013225. PubMed ID: 34528245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of epilepsy for people with Alzheimer's disease.
    Liu J; Wang LN
    Cochrane Database Syst Rev; 2021 May; 5(5):CD011922. PubMed ID: 33973646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topiramate for juvenile myoclonic epilepsy.
    Liu J; Tai YJ; Wang LN
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD010008. PubMed ID: 34817852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulthiame monotherapy for epilepsy.
    Milburn-McNulty P; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD010062. PubMed ID: 34554571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD001769. PubMed ID: 27123830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.
    Eaton C; Yong K; Walter V; Mbizvo GK; Rhodes S; Chin RF
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013136. PubMed ID: 35844168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Aug; (8):CD001911. PubMed ID: 26275105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.